ESMO: Pfizer, Astellas' latest Xtandi survival data may shore up prostate cancer lead over J&J
17th September 2021 Uncategorised 0 ESMO: Pfizer, Astellas’ latest Xtandi survival data may shore up prostate cancer lead over J&J
nhigginsdunn
Fri, 09/17/2021 – 08:23
More: ESMO: Pfizer, Astellas' latest Xtandi survival data may shore up prostate cancer lead over J&J
Source: fierce